Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 53 of the 53 references it cites were found in a registry or an index.

REporting recommendations for tumour MARKer prognostic studies (REMARK).

Open access
for the Statistics Subcommittee of the NCI-EORTC Working Group on Cancer Diagnostics, McShane, L M, Altman, D G, Sauerbrei, W, Taube, S E, Gion, M, Clark, G M · 2005 · British Journal of Cancer

Abstract

Despite years of research and hundreds of reports on tumour markers in oncology, the number of markers that have emerged as clinically useful is pitifully small. Often initially reported studies of a marker show great promise, but subsequent studies on the same or related markers yield inconsistent conclusions or stand in direct contradiction to the promising results. It is imperative that we attempt to understand the reasons that multiple studies of the same marker lead to differing conclusions. A variety of methodological problems have been cited to explain these discrepancies. Unfortunately, many tumour marker studies have not been reported in a rigorous fashion, and published articles often lack sufficient information to allow adequate assessment of the quality of the study or the generalisability of the study results. The development of guidelines for the reporting of tumour marker studies was a major recommendation of the US National Cancer Institute and the European Organisation for Research and Treatment of Cancer (NCI-EORTC) First International Meeting on Cancer Diagnostics in 2000. Similar to the successful CONSORT initiative for randomised trials and the STARD statement for diagnostic studies, we suggest guidelines to provide relevant information about the study design, preplanned hypotheses, patient and specimen characteristics, assay methods, and statistical analysis methods. In addition, the guidelines suggest helpful presentations of data and important elements to include in discussions. The goal of these guidelines is to encourage transparent and complete reporting so that the relevant information will be available to others to help them to judge the usefulness of the data and understand the context in which the conclusions apply.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/sj.bjc.6602678

Cites

53 of 53 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 52 references

Research works printed but not linked: 1

  1. Burke HB, Henson DE (1993) Criteria for prognostic factors and for an enhanced prognostic system. Cancer 72: 3131–3135 · doi:10.1002/1097-0142(19931115)72:10<3131::aid-cncr2820721039>3.0.co;2-j

Cited by

See all 1,394

Metadata

Authors
for the Statistics Subcommittee of the NCI-EORTC Working Group on Cancer Diagnostics, McShane, L. M., Altman, D. G., Sauerbrei, W., Taube, S. E., Gion, M., & Clark, G. M.
Affiliations
  • National Institutes of Health (US)
  • Cancer Research UK (GB)
  • University Medical Center Freiburg (DE)
  • Ospedale Civile di Venezia (IT)
Corresponding author
McShane, L M
Venue
British Journal of Cancer
Published
2005-08
Volume
93
Issue
4
Pages
387-391
ISSN
  • 0007-0920 (ISSN-L)
  • 1532-1827
OpenAlex
W2020016182
Cited by
1,394
References
52
Citations by year
2026: 79 · 2025: 79 · 2024: 98 · 2023: 78 · 2022: 77 · 2021: 87 · 2020: 124 · 2019: 112 · 2018: 105 · 2017: 75 · 2016: 74 · 2015: 58 · 2014: 92 · 2013: 62 · 2012: 47
FWCI
20.41
Type
journal article
Language
en
Open access
Locations
  • British Journal of Cancer (publishedVersion, cc-by-nc-sa)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • FreiDok plus (Universitätsbibliothek Freiburg) (submittedVersion)
Funders
  • European Organisation for Research and Treatment of Cancer
  • Translational Cancer Research Network
  • National Cancer Institute
Topics
  • Social Sciences › Decision Sciences › Statistics, Probability and Uncertainty › Meta-analysis and systematic reviews
  • Physical Sciences › Mathematics › Statistics and Probability › Statistical Methods in Epidemiology
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Clinical practice guidelines implementation
Keywords
tumor markers, prognostic factors, reporting guidelines, remarks, research transparency, research design, assay method, statistical analysis, cancer diagnosis, methodological discrepancies
MeSH terms
Humans, Neoplasms, Research Design, Biomarkers, Tumor, Information Dissemination, Biomedical Research

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: REporting recommendations for tumour MARKer prognostic studies (REMARK). https://app.cochat.ai/papers/10.1038/sj.bjc.6602678
The paper
for the Statistics Subcommittee of the NCI-EORTC Working Group on Cancer Diagnostics, McShane, L. M., Altman, D. G., Sauerbrei, W., Taube, S. E., Gion, M., & Clark, G. M. (2005). REporting recommendations for tumour MARKer prognostic studies (REMARK). British Journal of Cancer. https://doi.org/10.1038/sj.bjc.6602678

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.